MAS Sample Clauses

MAS. Except as set forth on Schedule 3.1 attached hereto, MAS represents and warrants: (a) MAS is validly existing and in good standing under the laws of the State of Texas. (b) The execution, delivery and authority to execute and deliver this Agreement has been duly authorized by all necessary action on the part of MAS. (c) MAS has the power and authority to execute and delivery this Agreement and to perform its obligations under this Agreement. (d) As of the date of this Agreement, it is not a party to any agreement or arrangement with any third party or under any obligation or restriction, including pursuant to its Articles of Incorporation or By-Laws, which in any way limits or conflicts with its ability to fulfill any of its obligations under this Agreement. (e) It is the owner of the entire right, title, and interest in and to the MAS Technology, that it has the sole right to grant licenses thereunder, and that it has not granted, and will not grant, licenses thereunder to any other entity that would restrict the rights granted to CTI hereunder. MAS also further represents that there are no agreements, written or oral, involving the MAS Technology and that it has delivered to CTI and its counsel all written agreements relating to the MAS Technology. (f) It is the exclusive licensee of the entire right, title, and interest in and to the Baylor Technology and the Improvements, that it has the sole right to grant sublicenses thereunder, and that it has not granted, and will not grant, sublicenses thereunder to any other entity that would restrict the rights granted to CTI hereunder. MAS also further represents that there are no agreements, written or oral, involving the Baylor Technology or the Improvements and that it has delivered to CTI and its counsel all written agreements relating to the Baylor Technology and the Improvements. (g) To the best of its knowledge, MAS owns or possesses sufficient legal rights to all patents, trade secrets, licenses, information, and proprietary rights and processes necessary for its business as now conducted and as proposed to be conducted without any conflict with, or infringement of the rights of, others. There are no outstanding options, licenses, or agreements of any kind relating to the foregoing, nor is MAS bound by or a party to any options, licenses or agreements of any kind with respect to the patents, trade secrets, licenses, information, and proprietary rights and processes of any other person or entity. MAS has...

MAS. Except as set forth on Schedule 3.1 attached hereto, MAS represents and warrants that:

MAS. MAS represents and warrants, after due inquiry by its directors and officers, and covenants that: (a) It is a corporation duly organized, validly existing and in good standing under the laws of the State of Texas; (b) Exhibit A is a true and accurate copy of the Baylor Agreement, which has not been amended, modified or otherwise altered prior to the Execution Date; and (c) Exhibit D and Exhibit E are true and accurate copies of the LumiCyte Agreement and the LumiGen Agreement, respectively, prior to giving effect to the amendments set forth in Section 2.1 and Section 2.2, respectively, of the Assignment Agreement.

MAS. All images assessed were reconstructed on a sharp (B60) algorithm (Siemens). All dogs had been positioned in sternal recumbency, with the limb of interest extended, ensuring there was no supination or pronation of the elbow. For each elbow three dimensional multiplanar reconstruction (MPR) views were created using OsiriX (version 5.6 32-bit, Pixmeo, Geneva) open source DICOM viewer, permitting transverse, dorsal and sagittal images to be viewed concurrently. Repeatable slice alignment was achieved by aligning slices with the caudal cortex of the ulna in the sagittal view and lateral aspect of the ulna in the dorsal view (Fig 1). Once the alignment was complete, the sagittal view was used to center the image on the most cranial part of the proximal ulna, immediately distal to the humeral condyle resulting in a repeatable standardised transverse image through the apex of the MCP. The transverse plane was chosen as the medial coronoid process is best defined in this plane (Xxxxxxx 1999). A window width of 3500 HU as previously recommended (Xxxxxxxx et al. 2007) and window level of 700 HU were used. A single transverse image for each elbow was archived as a JPEG file. Four board certified orthopaedic surgeons, two board certified radiologists, one diagnostic imaging resident and one surgical resident reviewed individually a single transverse CT image of the ulna at the level of the medial coronoid process from each elbow included in the study. All except one of the observers had been working together in the same institution for at least six months prior to the study. Each observer was asked to draw a line on the transverse CT image representing where, if present, they considered the junction between the normal and the sclerotic trabecular bone pattern to be delineated. This measurement was made on each transverse CT image by the eight observers twice (separated by 4 weeks). A single observer (XX) then used a sclerometer to quantify, as a percentage, the position of the observer’s line demarcating the transition between normal and sclerotic trabecular bone. The use of a sclerometer was firstly reported by Xxxxx et al. (2009) who applied the technique to quantify ulna sclerosis on lateral radiographs of the elbow from dogs with MCPD. Here, we applied the instrument to transverse CT images of the ulna at the level of the MCP. The sclerometer (Fig 2A) was superimposed on the image with the cranial line of the sliding scale being aligned with the most cranial corte...

MAS. MAS represents and warrants, after due inquiry by its directors and officers, and covenants that: (a) The execution and delivery of this Assignment Agreement has been duly authorized by all necessary action on the part of MAS (including its board of directors and shareholders, as necessary); (b) It has the power and authority to execute and deliver this Assignment Agreement and to perform its obligations and grant the rights granted under this Assignment Agreement; (c) As of the Execution Date, it is not a party to any agreement or arrangement with any Person, or to any obligation or restriction, including pursuant to its Articles of Incorporation or Bylaws, which in any way limits or conflicts with its ability to fulfill any of its obligations under this Assignment Agreement; (d) As of the Execution Date, MAS is not aware of any action, suit, proceeding, or investigation pending or currently threatened against MAS that questions the validity of this Assignment Agreement, or the right of MAS to enter into and deliver this Assignment Agreement, or to consummate the transactions contemplated hereby; and (e) As of the Effective Date, there is no MAS Assigned Technology.

MAS. The data used here are therefore insufficient to provide a full analysis of how the scan dose affects the outcome of our system. However, we believe it is likely that using data with a better signal-to-noise ratio would improve the system results. Nonetheless, it is advantageous to have shown that the system is also capable of working on low-dose data which can be acquired with less risk to the subject.

MAS. It will be specific to the needs of each company. ITAs will continue to supply advice, support and access through UKTI’s overseas network and through UKTI services such as OMIS, ECR and EMRS. Eligible companies are innovative and have between 2 and 10 years experience of exporting. Their needs are therefore likely to be more complex than those of P2E companies. No more than a third of Gateway to Global Growth clients are likely to be companies that have previously benefited from the P2E scheme.

MAS place, the Local Union shall be provided with a copy of the current form(s) being used for employee evaluation for release and general job descriptions. This information shall be gener- al in nature, not employee specitic. When a modified work assignment is made, the employee shall be provided with the hours and days he/she is scheduled to work as well as the nature of the work to be performed in writing. A copy of this notice shall also be submitted to the Local Union. + An employee who is placed in a modified work position may be subject to medical evaluation(s) by a physician selected by the Employer to determine if the modified work being per- formed is accelerating the rehabilitative process as anticipated by Section 2 above. [n the event such medical evaluation(s) determine that the rehabilitative process is not being accelerat- ed, the employee shall have the right to seek a second opinion from a physician of his choosing. Any disputes regarding con- flicting medical claims shall be resolved in accordance with the provisions outlined above. The employee may be removed from the modified work program based upon final medical findings under this procedure. Employees so removed shall not have their worker's compensation benefits affected because of such removal. In the event the employee's tempo- rary disability worker's compensation benefit is subject to reduction by virtue of an applicable Federal or State statute, the Employer shall pay the difference between the amount of the reduced temporary worker's compensation benetit to which the employee would be entitled. Modified work shall be restricted to the type of work that is not expected to result in a re-injury and which can be per- formed within the medical limitations set forth by the attend- ing physician. In the event the employee, in hislher judgment, is physically unable to perform the modified work assigned, he/she shall be either reassigned modified work within his/her physical capabilities or returned to full "temporary total" worker's compensation benefits. In the event a third (3rd) party insurance carrier refuses to reinstate such employee to full temporary total disability benefits, the Employer shall be required to pay the difference between the amount of the ben- efit paid by such third (Jrd) party insurer and full total tempo- rary disability benetits. Determination of physical capabilities shall be based on the attending physicians medical evaluation. Under no conditions will the in...

MAS. It will be specific to the needs of each company. ITAs will continue to supply advice, support and access through UKTI’s overseas network and through UKTI services such as OMIS, ECR and EMRS. Eligible companies are innovative and have between 2 and 10 years experience of exporting. Their needs are therefore likely to be more complex than those of P2E companies. No more than a third of Gateway to Global Growth clients are likely to be companies that have previously benefited from the P2E scheme. This is largely a Regional ITT delivered programme with support from the Regional Director's team. The Regional ITT will be responsible for: recruiting participants; organising training and master classes and booking participants; taking clients through the support process including action planning; and

MAS. The MAS System developed by FDRI pursuant to this Agreement shall be the sole and exclusive property of FDRI, and, subject to any rights PRODIGY may have to license such System pursuant to this Agreement, PRODIGY acknowledges and agrees that all rights, title and interests in and to the MAS System, including, without limitation maskworks, firmware, computer programs, algorithms, subroutines, methods, concepts, designs, know-how, techniques, data or other information of or concerning the MAS System Contract #3284 are and shall remain the sole and exclusive property of FDRI; provided, however, that all Confidential Information of PRODIGY used by FDRI to develop the MAS System shall be subject to the Confidentiality Agreement between the parties dated August 8, 1991; and provided, further, that during the Original Term and any Renewal Period, FDRI shall not license or sell the MAS System, including any modules or subsystems of the MAS System, nor use the MAS System, or any modules or subsystems thereof, to provide data processing services to any third party that is a direct competitor of PRODIGY in a line of business provided on a commercial basis by PRODIGY, whether on-line or otherwise, domestically or internationally. Except for any patent, copyright, trademark or other proprietary right retained by PRODIGY in any Confidential Information of PRODIGY disclosed to FDRI under the terms of the above-referenced Confidentiality Agreement and used by FDRI to develop the MAS System, FDRI shall be the exclusive owner of all copyrights, patents, patent application rights, corporate name and trademarks embodied in or applicable to or noted in the MAS System or any components or subsystems thereof. In the event of a conflict between this subsection 1.1.8.2(a)(ii) and any provision of the above-referenced Contract #3284 Confidentiality Agreement, the language contained herein shall prevail.